Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON-PFT, and FREEDOM trials

Circulating Osteocalcin Level Is Not Associated With Incident Type 2 Diabetes in Middle-Aged Male Subjects: Mean 8.4-year retrospective follow-up study

(2012) Y.-C. Hwang et al.   DIABETES CARE

Socioeconomic position and the incidence of type 2 diabetes: the ELSA study

(2012) Panayotes Demakakos et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Vitamin K-Dependent Carboxylation of Osteocalcin: Friend or Foe?

(2012) Caren M. Gundberg et al.   Advances in Nutrition

Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate

(2011) Peter Vestergaard   CALCIFIED TISSUE INTERNATIONAL

A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort

(2011) Chardpraorn Ngarmukos et al.   CLINICAL ENDOCRINOLOGY

Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study)

(2011) Anne L. Schafer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of phylloquinone supplementation on glucose homeostasis in humans

(2010) Rajiv Kumar et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Bone and glucose metabolism: A two-way street

(2010) Katherine J. Motyl et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism

(2010) Mathieu Ferron et al.   CELL

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

γ-Carboxylation of osteocalcin and insulin resistance in older men and women

(2009) M Kyla Shea et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

(2009) Pierre D Delmas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low Serum Levels of Undercarboxylated Osteocalcin in Postmenopausal Osteoporotic Women Receiving an Inhibitor of Bone Resorption

(2009) Hiroshi Aonuma et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

(2008) A. Lipton et al.   CLINICAL CANCER RESEARCH

Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women

(2008) M. Yoshida et al.   DIABETES CARE

The Danish National Diabetes Register: trends in incidence, prevalence and mortality

(2008) B. Carstensen et al.   DIABETOLOGIA

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

(2008) Makoto Hirao et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Association between Serum Osteocalcin and Markers of Metabolic Phenotype

(2008) Anastassios G. Pittas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women

(2008) Andrew Grey et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

(2008) Mathieu Ferron et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA